- Home
- CDIO vs LSH Comparison
CDIO vs LSH Comparison
Compare CDIO & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDIO
- LSH
- Stock Information
- Founded
- CDIO 2017
- LSH 2018
- Country
- CDIO United States
- LSH United States
- Employees
- CDIO N/A
- LSH N/A
- Industry
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- LSH
- Sector
- CDIO Health Care
- LSH
- Exchange
- CDIO Nasdaq
- LSH NYSE
- Market Cap
- CDIO 7.9M
- LSH 7.3M
- IPO Year
- CDIO N/A
- LSH 2024
- Fundamental
- Price
- CDIO $3.44
- LSH $0.88
- Analyst Decision
- CDIO Buy
- LSH
- Analyst Count
- CDIO 1
- LSH 0
- Target Price
- CDIO $60.00
- LSH N/A
- AVG Volume (30 Days)
- CDIO 57.8K
- LSH 13.3K
- Earning Date
- CDIO 08-11-2025
- LSH 08-01-2025
- Dividend Yield
- CDIO N/A
- LSH N/A
- EPS Growth
- CDIO N/A
- LSH N/A
- EPS
- CDIO N/A
- LSH N/A
- Revenue
- CDIO $19,902.00
- LSH $16,270,095.00
- Revenue This Year
- CDIO $1,434.82
- LSH N/A
- Revenue Next Year
- CDIO $4,661.91
- LSH N/A
- P/E Ratio
- CDIO N/A
- LSH N/A
- Revenue Growth
- CDIO N/A
- LSH N/A
- 52 Week Low
- CDIO $3.22
- LSH $0.84
- 52 Week High
- CDIO $53.10
- LSH $5.37
- Technical
- Relative Strength Index (RSI)
- CDIO 32.36
- LSH N/A
- Support Level
- CDIO $3.65
- LSH N/A
- Resistance Level
- CDIO $4.18
- LSH N/A
- Average True Range (ATR)
- CDIO 0.31
- LSH 0.00
- MACD
- CDIO 0.12
- LSH 0.00
- Stochastic Oscillator
- CDIO 4.49
- LSH 0.00
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.
About LSH LAKESIDE HOLDING LTD
Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.